Market Overview

Mirati Therapeutics (NASDAQ: MRTX)

73.95 -1.40 (-1.86%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/05/19Cantor FitzgeraldInitiates Coverage OnNeutral0.0
2/15/19PiperJaffrayInitiates Coverage OnOverweight0.0
10/29/18GuggenheimUpgradesBuy0.0
3/12/18BarclaysInitiates Coverage OnOverweight44.0
3/05/18CitigroupMaintainsBuy37.0
12/21/17Cowen & Co.Initiates Coverage OnOutperform
11/14/17H.C. WainwrightMaintainsBuy17.0
11/14/17Leerink SwannUpgradesOutperform
10/12/17H.C. WainwrightAssumesBuy20.0
9/19/17OppenheimerInitiates Coverage OnOutperform18.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter